Journal Home
Search for

Volume 64, Issue 1, Pages 33-36 (2005)


View previous. 42 of 49 View next.

Can SSRIs reduce the risk of preeclampsia in pregnant, depressed patients?

Shandara Durkee DawesCorresponding Author Information1email addressemail address

Received 30 May 2003; accepted 17 October 2003. published online 28 September 2004.

Summary 

Preeclampsia causes substantial morbidity and mortality. A significant part of the etiology of preeclampsia involves endothelial damage and platelet activation and in this way can be conceived as an illness with a pathophysiology similar to coronary artery disease. Depression is an independent risk factor for the progression of cardiovascular disease [Am Heart J 140 (2000) S57] and there is evidence to suggest that it may be a risk factor for preeclampsia as well. SSRIs have been shown to reduce the progression of coronary artery disease, independent of improvement in mood. SSRIs may also reduce risk factors for preeclampsia in addition to treating depression in pregnancy. This is an important area for further research.

Department of Psychiatry, Los Angeles Neuropsychiatric Institute, University of California, 760 Westwood Plaza, Room C8-846, Los Angeles, CA 90024, USA

Corresponding Author InformationTel.: +1 310 267 2095; fax: +1 310 825 0340

 This paper was written without grant support.

1 Present address: 301 Loyola Drive, Santa Barbara, CA 93109, USA. Tel.: +1 805 966 3935.

PII: S0306-9877(04)00429-3

doi:10.1016/j.mehy.2003.10.038


View previous. 42 of 49 View next.